We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into AMN Healthcare (AMN) Q4: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, AMN Healthcare Services (AMN - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.52 per share, reflecting a decline of 60.6% compared to the same period last year. Revenues are forecasted to be $695.12 million, representing a year-over-year decrease of 15.1%.
The consensus EPS estimate for the quarter has been revised 7.2% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain AMN Healthcare metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts expect 'Revenue- Physician and leadership solutions' to come in at $173.52 million. The estimate points to a change of +3.2% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Nurse and allied solutions' will reach $418.84 million. The estimate suggests a change of -22.1% year over year.
The average prediction of analysts places 'Revenue- Technology and workforce solutions' at $102.79 million. The estimate indicates a change of -8.7% from the prior-year quarter.
The consensus estimate for 'Physician and leadership solutions - Days Filled' stands at 52.75 million. Compared to the current estimate, the company reported 49.65 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Physician and leadership solutions - Revenue per day filled' of $2.56 million. The estimate is in contrast to the year-ago figure of $2.49 million.
According to the collective judgment of analysts, 'Segment operating income- Nurse and allied solutions' should come in at $37.07 million. The estimate is in contrast to the year-ago figure of $62.84 million.
Analysts predict that the 'Segment operating income- Technology and workforce solutions' will reach $39.11 million. The estimate compares to the year-ago value of $41.44 million.
The combined assessment of analysts suggests that 'Segment operating income- Physician and leadership solutions' will likely reach $18.54 million. The estimate compares to the year-ago value of $21.80 million.
Over the past month, shares of AMN Healthcare have returned -9.5% versus the Zacks S&P 500 composite's +4.7% change. Currently, AMN carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into AMN Healthcare (AMN) Q4: Wall Street Projections for Key Metrics
In its upcoming report, AMN Healthcare Services (AMN - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.52 per share, reflecting a decline of 60.6% compared to the same period last year. Revenues are forecasted to be $695.12 million, representing a year-over-year decrease of 15.1%.
The consensus EPS estimate for the quarter has been revised 7.2% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain AMN Healthcare metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts expect 'Revenue- Physician and leadership solutions' to come in at $173.52 million. The estimate points to a change of +3.2% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Nurse and allied solutions' will reach $418.84 million. The estimate suggests a change of -22.1% year over year.
The average prediction of analysts places 'Revenue- Technology and workforce solutions' at $102.79 million. The estimate indicates a change of -8.7% from the prior-year quarter.
The consensus estimate for 'Physician and leadership solutions - Days Filled' stands at 52.75 million. Compared to the current estimate, the company reported 49.65 million in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Physician and leadership solutions - Revenue per day filled' of $2.56 million. The estimate is in contrast to the year-ago figure of $2.49 million.
According to the collective judgment of analysts, 'Segment operating income- Nurse and allied solutions' should come in at $37.07 million. The estimate is in contrast to the year-ago figure of $62.84 million.
Analysts predict that the 'Segment operating income- Technology and workforce solutions' will reach $39.11 million. The estimate compares to the year-ago value of $41.44 million.
The combined assessment of analysts suggests that 'Segment operating income- Physician and leadership solutions' will likely reach $18.54 million. The estimate compares to the year-ago value of $21.80 million.
View all Key Company Metrics for AMN Healthcare here>>>
Over the past month, shares of AMN Healthcare have returned -9.5% versus the Zacks S&P 500 composite's +4.7% change. Currently, AMN carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>